Merck/Schering Terminate Respiratory Partnership
This article was originally published in The Pink Sheet Daily
Firms withdraw NDA for Singulair/Claritin combination.
You may also be interested in...
Agency's review of Singulair safety, centered on suicidal thinking and behavior, at issue.
Sanofi will fill and package 100 million doses of a rival vaccine for the European market in 2021 in a sign of how the industry is working to meet an unprecedented demand for COVID-19 vaccines.
Data from a high-profile Phase III COVID-19 vaccine trial will be released the first week of February, management said.